Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device

Go back to Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device
(NASDAQ: COCH) Delayed: 0.71 --0 (-0%)
Previous Close $0.71    52 Week High
Open $0.72    52 Week Low
Day High $0.73    P/E N/A 
Day Low $0.71    EPS
Volume 45,932